|
|
|
|
|
Detail |
| hsa-miR-16-1 |
|
Causal |
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Unspecified |
Expression profiling identifies microRNA signature in pancreatic cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Unspecified |
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. |
2005 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
miR-15 and miR-16 induce apoptosis by targeting BCL2. |
2005 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
miR-15a and miR-16-1 down-regulation in pituitary adenomas. |
2005 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. |
2008 |
|
|
|
|
|
|